000 01211 a2200349 4500
005 20250512200354.0
264 0 _c19841025
008 198410s 0 0 eng d
022 _a0302-282X
024 7 _a10.1159/000118074
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPöldinger, W J
245 0 0 _aMelperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study.
_h[electronic resource]
260 _bNeuropsychobiology
_c1984
300 _a181-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aAnxiety Disorders
_xdrug therapy
650 0 4 _aButyrophenones
_xadverse effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPsychiatric Status Rating Scales
773 0 _tNeuropsychobiology
_gvol. 11
_gno. 3
_gp. 181-6
856 4 0 _uhttps://doi.org/10.1159/000118074
_zAvailable from publisher's website
999 _c6147856
_d6147856